The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature
- PMID: 3036083
- PMCID: PMC1147681
- DOI: 10.1042/bj2420185
The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature
Abstract
We have previously shown that the mono [125I]iodinated vasoactive intestinal peptide (125I-VIP) could be covalently cross-linked on intact colonic adenocarcinoma cells (HT29). A major Mr 67,000 and a minor Mr 120,000 cross-linked polypeptides have been characterized [Muller, Luis, Fantini, Abadie, Giannellini, Marvaldi & Pichon (1985) Eur. J. Biochem. 151, 411-417]. The glycoprotein nature of these species was investigated using endo-beta-acetylglucosaminidase F (Endo F) treatment, enzymic and chemical desialylation and wheat germ agglutinin (WGA)-Sepharose affinity chromatography. Affinity-labelled VIP-binding proteins solubilized by Nonidet P-40 bound to WGA-Sepharose and could be eluted specifically with N-acetyl-D-glucosamine. Treatment with Endo F resulted in an increased electrophoretic mobility of both polypeptides. The major and the minor VIP-binding proteins were converted respectively into Mr 47,000 and 100,000 species, indicating removal of 20 kDa of N-linked oligosaccharides. Deglycosylation with trifluoromethanesulphonic acid also led to a 20 kDa loss in mass of the Mr 67,000 component, indicating the absence of additional O-linked sugars on this polypeptide. The presence of sialic acid on the major VIP-binding protein was demonstrated after treatment of intact cells with neuraminidase or by chemical desialylation with hydrochloric acid. We conclude from this study that the VIP receptor from intact HT29-D4 cells is a glycoprotein with N-linked oligosaccharide side chains containing sialic acid.
Similar articles
-
Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.Biochem J. 1988 Mar 15;250(3):679-85. doi: 10.1042/bj2500679. Biochem J. 1988. PMID: 2839143 Free PMC article.
-
Analysis of cholecystokinin-binding proteins using endo-beta-N-acetylglucosaminidase F.J Cell Biol. 1984 Sep;99(3):1110-6. doi: 10.1083/jcb.99.3.1110. J Cell Biol. 1984. PMID: 6088554 Free PMC article.
-
The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis.Biochimie. 1988 Oct;70(10):1311-22. doi: 10.1016/0300-9084(88)90002-8. Biochimie. 1988. PMID: 2852963 Review.
-
Functional and immunological evidence for stable association of solubilized vasoactive-intestinal-peptide receptor and stimulatory guanine-nucleotide-binding protein from rat liver.Eur J Biochem. 1990 Feb 14;187(3):605-9. doi: 10.1111/j.1432-1033.1990.tb15343.x. Eur J Biochem. 1990. PMID: 2154377
-
HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.Biochimie. 1988 May;70(5):663-71. doi: 10.1016/0300-9084(88)90251-9. Biochimie. 1988. PMID: 2844304 Review.
Cited by
-
Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.Biochem J. 1988 Mar 15;250(3):679-85. doi: 10.1042/bj2500679. Biochem J. 1988. PMID: 2839143 Free PMC article.
-
Effect of inhibiting N-glycosylation or oligosaccharide processing on vasoactive intestinal peptide receptor binding activity and structure.Biochem J. 1991 Sep 1;278 ( Pt 2)(Pt 2):527-33. doi: 10.1042/bj2780527. Biochem J. 1991. PMID: 1654885 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources